Search »

Right-to-know: the importance of balancing transparency with protection of intellectual property

The Consumer Right to Know Act (Senate Bill 928) has been introduced in California and would require that our companies make publicly available their proprietary product formulations. Not only would this threaten U.S. jobs, but it also would set a very bad precedent for other industries.

No other industry is required to disclose its unique proprietary information to the public, and our industry should be no different. While we support sharing with the public more information about the ingredients in our products, this bill must include proper protections for confidential business information, which is the heart of innovation, competition and jobs creation in the U.S.

We propose that a legislative or regulatory approach to “right-to-know” could build upon a voluntary consumer product ingredient communication initiative that became effective the first of this year. In fact, we have for the past year been working to expand the program in an effort to reach agreement on the California bill and others that have been introduced at the federal level. We have come a long way in our negotiations and have arrived at what could be the most comprehensive right-to-know package anywhere in the world.

While we will continue to work with all stakeholders on this issue, we cannot agree to give away our product formulations. Our companies invest heavily in research and development to bring products to the marketplace, and those efforts need protections to assure companies their research and development investments cannot be stolen by domestic or foreign competitors. Without those protections, there is no incentive for innovation, which is essential to the development of safe and more sustainable products and jobs creation and retention in the United States.

Chris Cathcart, CSPA President

Tags: ,

Leave a Reply

Spam Protection by WP-SpamFree